Ambu stock rises 1.61 percent while staying 38.01 percent below high

Published on 09/28/2026 at 12:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ambu stock traded at DKK 69.30 on September 28, 2026, with a market value of DKK 18.4 billion. UBS cut its target to DKK 72.00 on September 15.

Schwarzweiß-Reportage aus dem Operationssaal mit Endoskopie-Technik — Ambu A/S (DK0060946788) dokumentiert schwarzweiß eine dramatische Operationssaal-Szene mit Endoskopie-Ausrüstung im Krankenhaus, Illustration mit AI erstellt.

Ambu stock (ISIN DK0060946788) was trading at DKK 69.30 on Nasdaq Copenhagen on September 28, 2026, up 1.61 percent from the prior close of DKK 68.20. The price remained 38.01 percent below its 52-week high of DKK 111.80, putting the medical-device company at a market capitalization of DKK 18.4 billion.

UBS lowers its price target

According to Zonebourse on September 15, 2026, UBS cut Ambu's rating from Buy to Neutral and reduced its price target from DKK 96.00 to DKK 72.00. The revised target stood 3.90 percent above the September 28 trading price, while the lower rating placed greater weight on execution and profitability.

The same UBS assessment cited annual sales growth of 10.30 percent for 2026 through 2030, compared with Ambu's stated target range of 11.00 percent to 13.00 percent. UBS also projected a 15.70 percent margin for 2028, below Ambu's 20.00 percent objective, making margin delivery a central test for the investment case.

TIMS adds an acquisition angle

Ambu's expansion strategy provides a counterpoint to the cautious analyst view. MarketScreener reported on September 14, 2026, that Ambu agreed to acquire US-based TIMS Medical for USD 45 million in cash plus potential earn-outs of up to USD 20 million.

The deal gives Ambu an additional platform in medical imaging and is intended to strengthen revenue growth and the EndoIntelligence platform, while the company's 2025/2026 outlook was unchanged in the report. The transaction therefore adds a growth lever, but the UBS figures show why investors are also measuring the company against its margin and sales targets.

Buyback supports the capital story

Ambu was also completing a DKK 300 million share buyback program during September. MarketScreener reported that Ambu had accumulated 4,285,739 repurchased shares by September 11, 2026, and held 8,435,350 treasury shares, equal to 3.10 percent of share capital. The program adds a capital-allocation element to the acquisition and operating-growth debate.

Ambu stock stays below its yearly high

Ambu stock was last trading at DKK 69.30 on Nasdaq Copenhagen on September 28, 2026, at 12:30 p.m. CEST, with a session range of DKK 68.85 to DKK 69.50 and volume of 135,478 shares.